Navigation Links
TruFUSE(R) Patents Awarded
Date:7/8/2008

CLEARWATER, Fla., July 8 /PRNewswire/ -- minSURG(TM) Corporation, through its parent company, Orthopedic Development Corporation, has received a Notice of Allowance from the United States Patent and Trademark Office on two of its pending US patent applications. The patents protect the designs of one of its TruFUSE(R) dowels and a Surgical Drill Guide, which is used in minSURG's proprietary TruFUSE Minimally Invasive Facet Fusion Procedures and Systems. The pending patents, once issued, will offer patent protection through 2022.

Six additional patent applications related to the TruFUSE product remain pending. TruFUSE uses specially designed bone dowels to stop facet joints from moving, which is intended to eliminate or dramatically reduce back pain caused by a variety of reasons. TruFUSE is also used to supplement other back surgeries when more invasive or destructive means are not required. The TruFUSE procedure is intended to fuse the facet joints through a natural healing process for a long-term solution. Because TruFUSE causes minimal tissue damage, it does not preclude other options, including non-surgical alternatives, and TruFUSE can be used earlier than other, more invasive spine fusion methods.

For more information on TruFUSE, please visit the Web site at http://www.trufuse.com or call (813) 318-0565 ext. 216.


'/>"/>
SOURCE minSURG(TM) Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Orthopedic Development Corporations TruFUSE(R) Procedure Tops 1,750 Patients in First Year
2. Over 600 Surgeons Certified to use TruFUSE(R) to Treat Back Pain Sufferers
3. TruFUSE(R) Minimally Invasive Facet Fusion Procedure Tops 3,000 Spinal Levels
4. Start Licensing, Inc. Further Strengthens Position in Cloning Industry With New Patents
5. Cyberonics Licenses Obesity-Related Patents
6. Neuralstem Responds to Incorrect StemCells, Inc. Release on Patents
7. The Quantum Group Files Four Additional Patents
8. Jury Validates Key Mannatech Technology Patents Involving Its Ambrotose(R) Glyconutrient Products
9. Telik Announces Patents on Compounds Related to TELINTRA
10. UVa researcher awarded $3.6 million grant to fight drug-resistant bacteria
11. Southwest Ambulance Awarded Exclusive, 3-Year Contract Extension in Peoria, Arizona
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2015)... Final Cut Pro X plugin ... Studios, entitled TranSports. , “TranSports is a compilation ... Pro X,” said Christiana Austin, CEO of Pixel Film ... effortlessly transition using this cool sports transition tool.” , ... styled transition pack for Final Cut Pro X. TranSports ...
(Date:3/28/2015)... March 28, 2015 Could genetic code ... new study by researchers at the Harvard ... with the support of the Coffee and Caffeine Genetics ... Psychiatry this past fall, the study—one of several recent ... genomic data from more than 120,000 regular coffee drinkers ...
(Date:3/28/2015)... The California-based leading wig brand UniWigs has prepared a ... during the Easter Holidays from today until April 6th. ... Fools’ Day. , As the winter fades and spring ... Festival, with religious origins to countries in Europe and ... The best wig provider, UniWigs, would like to offer ...
(Date:3/28/2015)... NV (PRWEB) March 28, 2015 Pitching speed, ... a history of shoulder and elbow injuries, according to new ... Medicine’s ( AOSSM ) Specialty Day. , “Our findings indicate ... a 20% increase in likelihood of a history of injury, ... with a 12% increase likelihood of a history of injury, ...
(Date:3/28/2015)... Raleigh, NC (PRWEB) March 28, 2015 ... people with peritoneal mesothelioma, revealing, for the first time, ... Click here to read the newly posted story ... scientists at the University of British Columbia, the British ... used genome mapping to reveal underlying molecular alterations and ...
Breaking Medicine News(10 mins):Health News:Introducing TranSports for Final Cut Pro X Users from Pixel Film Studios 2Health News:How Coffee Habits Relate to Our Genetic Code and Enhancing the Caffeine Experience 2Health News:How Coffee Habits Relate to Our Genetic Code and Enhancing the Caffeine Experience 3Health News:UniWigs Is Sending Out Mysterious Gifts During the Easter Holidays 2Health News:Researchers Highlight Shoulder and Elbow Injury Possibility in Youth Players 2Health News:New Genomics Research May Help Doctors Tailor Mesothelioma Treatment, According to Surviving Mesothelioma 2
... The increase in the number of U.S. medical students ... sign toward easing the primary care workforce shortage, according ... second-largest doctors group. The 2011 National Resident Matching ... from last year, with 2,940 U.S. seniors at medical ...
... Arbor, Mich. Providing kidney transplants to patients with ... transplant operations and improve life span after kidney transplant, ... the New England Journal of Medicine March 16., Alan ... and his co-authors endorsed new concepts designed to improve ...
... N.J. (March 16, 2011) The Multiple Myeloma Research ... Hackensack University Medical Center, member of the Multiple Myeloma ... in Multiple Myeloma Patient Symposium on Saturday, April 2 ... program is for patients and caregivers who want to ...
... released new official clinical guidelines on the diagnosis ... statement replaces ATS guidelines published in 2000, and ... and management of IPF, as well as available ... palliative care. , The statement appears in the ...
... By Maureen Salamon HealthDay Reporter , ... on Parkinson,s disease patients significantly improved the tremors, rigidity ... the illness, a small new study reports. The ... advanced Parkinson,s disease, with half randomly assigned to receive ...
... shows that it is feasible to screen for undiagnosed ... arrest (SCA). Adding a 10-minute electrocardiogram (EKG or ECG) ... of potentially serious heart conditions. Although more ... relatively low-cost screening might help identify children who are ...
Cached Medicine News:Health News:Residency match results encouraging for adults needing primary care 2Health News:Survival matching should be used to allocate donated kidneys to transplant recipients 2Health News:Survival matching should be used to allocate donated kidneys to transplant recipients 3Health News:The MMRF and John Theurer Cancer Center to host patient symposium 2Health News:ATS issues joint statement on the treatment of idiopathic pulmonary fibrosis 2Health News:ATS issues joint statement on the treatment of idiopathic pulmonary fibrosis 3Health News:ATS issues joint statement on the treatment of idiopathic pulmonary fibrosis 4Health News:Gene Therapy May Help Reverse Parkinson's Symptoms 2Health News:Gene Therapy May Help Reverse Parkinson's Symptoms 3Health News:In pilot study, screening detects potentially serious heart conditions in healthy children 2
(Date:3/27/2015)... March 27, 2015 XRpro Sciences, Inc., ... discovery and development services which features high throughput ... industry, announced financial results for the year ended ...  Tyson, Chairman of XRpro Sciences commented, "We have ... from development stage to commercial stage in large ...
(Date:3/27/2015)... March 27, 2015 According to ... (Diagnostic Catheter (Conventional, Advanced, Ultrasound), Ablation Catheter (Cryoablation, RF, ... Indication (AF, VT, WPW) - Global Forecasts to 2019 ", ... to reach around ~$4.73 Billion by 2019 with a ... to 2019. Browse   90   ...
(Date:3/27/2015)... Mass. , March 27, 2015 /PRNewswire/ ... and privately-held MirImmune LLC, today announced that ... agreement to RXi,s novel and proprietary sd-rxRNA® ... cancer immunotherapies. The collaboration has the potential ... patient friendly cancer treatments that could be ...
Breaking Medicine Technology:XRpro Sciences Announces Fiscal 2014 Financial Results 2XRpro Sciences Announces Fiscal 2014 Financial Results 3XRpro Sciences Announces Fiscal 2014 Financial Results 4Electrophysiology (EP) Market Worth $4.73 Billion by 2019 2Electrophysiology (EP) Market Worth $4.73 Billion by 2019 3Electrophysiology (EP) Market Worth $4.73 Billion by 2019 4RXi Pharmaceuticals and MirImmune LLC Enter into an Exclusive Licensing Agreement for RXi's Self-Delivering RNAi (sd-rxRNA) Technology to Develop Cell-based Immunotherapies to Treat Cancer 2RXi Pharmaceuticals and MirImmune LLC Enter into an Exclusive Licensing Agreement for RXi's Self-Delivering RNAi (sd-rxRNA) Technology to Develop Cell-based Immunotherapies to Treat Cancer 3RXi Pharmaceuticals and MirImmune LLC Enter into an Exclusive Licensing Agreement for RXi's Self-Delivering RNAi (sd-rxRNA) Technology to Develop Cell-based Immunotherapies to Treat Cancer 4RXi Pharmaceuticals and MirImmune LLC Enter into an Exclusive Licensing Agreement for RXi's Self-Delivering RNAi (sd-rxRNA) Technology to Develop Cell-based Immunotherapies to Treat Cancer 5
5mm from bend to tip 0.3x2.0mm Tip, Oblong 2 Sided Straight, at 45 degrees; In Titanium...
Angled 40 Degrees, 0.6x0.8 Elliptical Tip; in Titanium...
Double ended with 0.5mm x 10mm and 1.0mm x 15mm blades; both blades gently curved; round serrated handle, In Titanium....
Bend with "H" Shaped Tip, LEFT; in Titanium....
Medicine Products: